Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythritol Air-Powder vs Standard Treatment for Peri-implant Mucositis
NCT03915665Completed
- Sponsor
- IRCCS Ospedale Galeazzi-Sant'Ambrogio
- Start
- Apr 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Randomised, single-blind trial in peri-implant mucositis (2 arms), sponsored by IRCCS Ospedale Galeazzi-Sant'Ambrogio. Primary endpoint: Bleeding index change at 3 months. Started Apr 2019; status: completed.
02
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on NCT03915665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915665.